1. Home
  2. CVAC vs PSIX Comparison

CVAC vs PSIX Comparison

Compare CVAC & PSIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • PSIX
  • Stock Information
  • Founded
  • CVAC 2000
  • PSIX 1985
  • Country
  • CVAC Germany
  • PSIX United States
  • Employees
  • CVAC N/A
  • PSIX N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • PSIX Industrial Machinery/Components
  • Sector
  • CVAC Health Care
  • PSIX Industrials
  • Exchange
  • CVAC Nasdaq
  • PSIX Nasdaq
  • Market Cap
  • CVAC 818.8M
  • PSIX 801.5M
  • IPO Year
  • CVAC 2020
  • PSIX N/A
  • Fundamental
  • Price
  • CVAC $3.12
  • PSIX $24.51
  • Analyst Decision
  • CVAC Buy
  • PSIX Strong Buy
  • Analyst Count
  • CVAC 2
  • PSIX 1
  • Target Price
  • CVAC $10.00
  • PSIX $37.00
  • AVG Volume (30 Days)
  • CVAC 717.4K
  • PSIX 398.8K
  • Earning Date
  • CVAC 04-10-2025
  • PSIX 01-01-0001
  • Dividend Yield
  • CVAC N/A
  • PSIX N/A
  • EPS Growth
  • CVAC N/A
  • PSIX 162.71
  • EPS
  • CVAC 0.75
  • PSIX 3.01
  • Revenue
  • CVAC $554,073,921.00
  • PSIX $475,967,000.00
  • Revenue This Year
  • CVAC N/A
  • PSIX $9.27
  • Revenue Next Year
  • CVAC $66.34
  • PSIX $11.18
  • P/E Ratio
  • CVAC $4.19
  • PSIX $8.14
  • Revenue Growth
  • CVAC 895.54
  • PSIX 3.70
  • 52 Week Low
  • CVAC $2.22
  • PSIX $2.00
  • 52 Week High
  • CVAC $5.28
  • PSIX $45.74
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 53.48
  • PSIX N/A
  • Support Level
  • CVAC $3.05
  • PSIX N/A
  • Resistance Level
  • CVAC $3.02
  • PSIX N/A
  • Average True Range (ATR)
  • CVAC 0.19
  • PSIX 0.00
  • MACD
  • CVAC 0.06
  • PSIX 0.00
  • Stochastic Oscillator
  • CVAC 79.14
  • PSIX 0.00

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About PSIX Power Solutions International Inc. Common Stock

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction, and irrigation. The company generates majority of its sales from United States.

Share on Social Networks: